Key result
COVID-19 infection linked to ~20% higher odds of new CVD in adults over 50.
Why the study?
To extend research on the connection between COVID-19 and CVD at a macro level across Europe and highlight the virus's effects on heart health at country and continental levels.
Does COVID-19 infection increase cardiovascular disease risk in individuals aged 50 and over?
Observational (n=26,895)
Yes
Does COVID-19 infection increase cardiovascular disease risk in individuals aged 50 and over?
COVID-19 infection is associated with a 20% average increase in cardiovascular disease risk among older adults in Europe, with hypertension acting as a significant interacting risk factor.
Answers are grounded in this paper and cite their sources.
May warrant post-COVID CVD vigilance in Europeans ≥50; leaves open causality and needs prospective trials before practice change.
Aim This study aims to extend the research on the connection between COVID-19 and cardiovascular disease (CVD) by exploring this link at a macro level across the continent of Europe. We aim to highlight the virus’s detrimental effects on heart health at both country and continental levels. Subject and methods Utilizing data from the SHARE survey, we investigated the heart health impacts of COVID-19 on individuals aged 50 and over in 26 European countries. A Bayesian hierarchical logistic regression (BHLR) model was employed to assess country-level and continent-level effects, enabling us to account for geographical variations and estimate the overall continental impact. Results Our findings indicate a 20% average increase in CVD risk post-COVID-19 infection, associated with other risk factors such as hypertension, diabetes, chronic lung disease, and elevated BMI. Hypertension was particularly notable as a significant risk factor. Conclusions This study provides a comprehensive overview of how COVID-19 interacts with cardiovascular health risks across Europe. It reveals significant variability in the virus’s impact on heart health across different countries compared to the overall effect observed at the continental level. These insights contribute to a broader understanding of COVID-19’s implications for public health policy and individual risk management in the context of cardiovascular health.
No takes yet. Share an insight, caveat, or question.
Sefidi et al. (2024) conducted an observational in Cardiovascular disease (n=26,895). COVID-19 infection vs. No COVID-19 infection was evaluated on Incidence of cardiovascular disease (CVD) (OR 1.20, 95% CI 1.01-1.44). COVID-19 infection was associated with a 20% average increase in the odds of developing new cardiovascular disease among European adults aged 50 and older.
Synapse has enriched 10 related papers. Consider them for comparative context: